Literature DB >> 1866373

Structural requirements for the intestinal mucosal-cell peptide transporter: the need for N-terminal alpha-amino group.

P F Bai1, P Subramanian, H I Mosberg, G L Amidon.   

Abstract

The requirement for a free alpha-amino group for the intestinal peptide carrier-mediated transport was investigated. A series of dipeptide analogues without the N-terminal alpha-amino group [including phenylpropionylproline, phenylacetylproline, N-benzoylproline, phenylacetyl-alpha-methyldopa, and hippuric acid (N-benzoylglycine)] were studied in the perfused rat intestinal segment. The absorption of phenylpropionylproline, phenylacetyl-alpha-methyldopa, and N-benzoylproline was concentration dependent. The transport parameters (mean +/- SD) of phenylpropionylproline and N-benzoylproline were as follows: Jmax*, 0.037 (+/- 0.019) mM; Km, 0.045 (+/- 0.027) mM; Pc*, 0.830 (+/- 0.130); and Pm*, 0.673 +/- 0.049; and Jmax*, 1.34 (+/- 0.24) mM; Km, 1.31 (+/- 0.30) mM; Pc*, 1.02 (+/- 0.11); and Pm*, 0; respectively. The intestinal permeabilities of phenylpropionylproline, phenylacetylproline, N-benzoylproline, and hippuric acid (N-benzoylglycine) were significantly reduced by dipeptides and cephradine. These results strongly suggest that these dipeptide analogues, without an alpha-amino group, are transported by the peptide carrier and provide more direct evidence that a free alpha-amino group is not absolutely essential for the mucosal-cell peptide carrier-mediated transport.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866373     DOI: 10.1023/a:1015848522228

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Kinetics of Michaelis-Menten absorption of amino-penicillins in rats.

Authors:  A Tsuji; E Nakashima; I Kagami; T Asano; R Nakashima; T Yamana
Journal:  J Pharm Pharmacol       Date:  1978-08       Impact factor: 3.765

2.  Dipeptidylaminopeptidase and carboxypeptidase activities of the brush border of rabbit small intestine.

Authors:  S Auricchio; L Greco; B de Vizia; V Buonocore
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

3.  Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa.

Authors:  M Hu; P Subramanian; H I Mosberg; G L Amidon
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

4.  Evidence for a carrier-mediated transport system in the small intestine available for FK089, a new cephalosporin antibiotic without an amino group.

Authors:  A Tsuji; H Hirooka; I Tamai; T Terasaki
Journal:  J Antibiot (Tokyo)       Date:  1986-11       Impact factor: 2.649

5.  Intestinal absorption mechanism of amino-beta-lactam antibiotics. III. Kinetics of carrier-mediated transport across the rat small intestine in situ.

Authors:  E Nakashima; A Tsuji; S Kagatani; T Yamana
Journal:  J Pharmacobiodyn       Date:  1984-07

6.  A common mechanism for transport of di- and tri-peptides by hamster jejunum in vitro.

Authors:  J M Addison; D Burston; J A Dalrymple; D M Matthews; J W Payne; M H Sleisenger; S Wilkinson
Journal:  Clin Sci Mol Med       Date:  1975-10

7.  Evidence for active transport of tripeptides by hamster jejunum in vitro.

Authors:  J M Addison; D Burston; J W Payne; S Wilkinson; D M Matthews
Journal:  Clin Sci Mol Med       Date:  1975-10

8.  Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.

Authors:  D I Friedman; G L Amidon
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

9.  Effect of amino acids on purified rat intestinal brush-border membrane aminooligopeptidase.

Authors:  Y S Kim; E J Brophy
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

10.  Identification of proline-specific carboxypeptidase localized to brush border membrane of rat small intestine and its possible role in protein digestion.

Authors:  R H Erickson; I S Song; M Yoshioka; R Gulli; S Miura; Y S Kim
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

View more
  11 in total

1.  Improvement of the intestinal absorption of a peptidomimetic, boronic acid thrombin inhibitor possibly utilizing the oligopeptide transporter.

Authors:  H Saitoh; B J Aungst
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

Review 2.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

3.  Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.

Authors:  N J Snyder; L B Tabas; D M Berry; D C Duckworth; D O Spry; A H Dantzig
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  Carrier-mediated transport can obey fractal kinetics.

Authors:  P Macheras
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  Restricted intestinal absorption of some beta-lactam antibiotics by an energy-dependent efflux system in rat intestine.

Authors:  H Saitoh; H Fujisaki; B J Aungst; K Miyazaki
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

6.  Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line.

Authors:  Carsten Uhd Nielsen; Claudiu T Supuran; Andrea Scozzafava; Sven Frokjaer; Bente Steffansen; Birger Brodin
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 7.  Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.

Authors:  S M Catnach; P D Fairclough; S M Hammond
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

8.  Peptide carrier-mediated transport in intestinal brush border membrane vesicles of rats and rabbits: cephradine uptake and inhibition.

Authors:  H Yuasa; G L Amidon; D Fleisher
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

Review 9.  Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery.

Authors:  J P Bai; G L Amidon
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

10.  Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport?

Authors:  R G Schoenmakers; M C Stehouwer; J J Tukker
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.